Patents by Inventor David H. Gelfand

David H. Gelfand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10150990
    Abstract: The present application provides polynucleotides comprising 5?-tails with sequence segments useful for the detection of target nucleic acid sequences, and methods for their use in detecting target nucleic acids. The polynucleotides are used to amplify a subsequence of a target nucleic acid in the presence of one or more ribonucleotides. The ribonucleotides are incorporated into amplification products at regular intervals complementary to the 5?-tail sequence segments. Cleavage of amplification products at the bond immediately 3? to incorporated ribonucleotides produces detectably distinct fragments indicative of the presence or absence of a target nucleic acid.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: December 11, 2018
    Assignees: Roche Molecular Systems, Inc., CEA/Institut de Genomique—Centre National de Genotypage
    Inventors: David H. Gelfand, Ivo Glynne Gut, Keith A. Bauer, Florence Mauger
  • Patent number: 9206476
    Abstract: The invention provides a method of determining the nucleotide sequence of a target nucleic acid using a reversibly terminating nucleotide that is modified at the 2? position.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: December 8, 2015
    Assignee: ROCHE MOLECULAR SYSTEMS, INC
    Inventors: David H. Gelfand, Amar Gupta
  • Patent number: 9102924
    Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. The mutant polymerases overcome the inhibitory effects by an intercalating dye. Therefore, the mutant polymerases are useful in a variety of disclosed methods in combination with an intercalating dye. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: August 11, 2015
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko, Olga Budker, Nancy Schoenbrunner, Susanne Stoffel, Thomas Myers
  • Patent number: 8962293
    Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: February 24, 2015
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko, Thomas Myers
  • Publication number: 20110294168
    Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. The mutant polymerases overcome the inhibitory effects of a variety of polymerase and reverse transcriptase inhibitors. Therefore, the mutant polymerases are useful in a variety of disclosed methods in the presence of such inhibitors.
    Type: Application
    Filed: April 15, 2011
    Publication date: December 1, 2011
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko, Thomas Myers, Joseph San Filippo, Rachel Shahinian
  • Patent number: 7745125
    Abstract: The present invention provides reaction mixtures that include blocked oligonucleotides comprising 2?-terminator nucleotides. The blocked oligonucleotides are rendered extendible when the 2?-terminator nucleotides are removed from the oligonucleotides, e.g., via pyrophosphorolysis. The reaction mixtures can be used in various nucleic acid polymerization and/or amplification assays, among many other applications. In addition to reaction mixtures, the invention also provides related methods and reaction mixtures.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: June 29, 2010
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Keith A. Bauer, Amar P. Gupta, Veeraiah Bodepudi, John Niemiec
  • Publication number: 20090280539
    Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. The mutant polymerases overcome the inhibitory effects by an intercalating dye. Therefore, the mutant polymerases are useful in a variety of disclosed methods in combination with an intercalating dye. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: April 16, 2009
    Publication date: November 12, 2009
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko, Olga Budker, Nancy Schoenbrunner, Susanne Stoffel
  • Publication number: 20090263813
    Abstract: The present application provides polynucleotides comprising 5?-tails with sequence segments useful for the detection of target nucleic acid sequences, and methods for their use in detecting target nucleic acids. The polynucleotides are used to amplify a subsequence of a target nucleic acid in the presence of one or more ribonucleotides. The ribonucleotides are incorporated into amplification products at regular intervals complementary to the 5?-tail sequence segments. Cleavage of amplification products at the bond immediately 3? to incorporated ribonucleotides produces detectably distinct fragments indicative of the presence or absence of a target nucleic acid.
    Type: Application
    Filed: April 9, 2009
    Publication date: October 22, 2009
    Applicants: Roche Molecular Systems, Inc., Centre National de Genotypage
    Inventors: DAVID H GELFAND, Ivo Glynne Gut, Keith A. Bauer, Florence Mauger
  • Publication number: 20090148891
    Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Application
    Filed: October 17, 2007
    Publication date: June 11, 2009
    Applicant: Roche Molecular Systems, Inc
    Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko
  • Publication number: 20080293071
    Abstract: The invention provides a method of determining the nucleotide sequence of a target nucleic acid using a reversibly terminating nucleotide that is modified at the 2? position.
    Type: Application
    Filed: December 20, 2006
    Publication date: November 27, 2008
    Applicant: ROCHE MOLECULAR SYSTEMS, INC
    Inventors: David H. Gelfand, Amar Gupta
  • Patent number: 7445900
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides uses the 5? to 3? nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and release labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification, assay.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: November 4, 2008
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Publication number: 20080171315
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides uses the 5? to 3? nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and release labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification, assay.
    Type: Application
    Filed: August 11, 2005
    Publication date: July 17, 2008
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Patent number: 7148049
    Abstract: The present invention provides thermostable or thermoactive DNA polymerases with attenuated 3?-5? exonuclease activity, methods for their synthesis, methods for their use, kits comprising the polymerases, nucleic acids encoding the polymerases and cells comprising such a nucleic acid. The DNA polymerases of the invention are useful in many recombinant DNA techniques, such as nucleic acid amplification by the polymerase chain reaction. The DNA polymerases of the invention allow higher fidelity replication and amplification of a template DNA sequence, allow less degradation of primers and/or more efficient use of deoxynucleotide triphosphates and are in general more efficient and less costly to make and use.
    Type: Grant
    Filed: March 26, 2003
    Date of Patent: December 12, 2006
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Nancy J. Schoenbrunner, Thomas W. Myers, David H. Gelfand
  • Patent number: 7141377
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides uses the 5? to 3? nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and release labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification assay.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: November 28, 2006
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Publication number: 20040005599
    Abstract: The present invention provides thermostable or thermoactive DNA polymerases with attenuated 3′-5′ exonuclease activity, methods for their synthesis, methods for their use, kits comprising the polymerases, nucleic acids encoding the polymerases and cells comprising such a nucleic acid. The DNA polymerases of the invention are useful in many recombinant DNA techniques, such as nucleic acid amplification by the polymerase chain reaction. The DNA polymerases of the invention allow higher fidelity replication and amplification of a template DNA sequence, allow less degradation of primers and/or more efficient use of deoxynucleotide triphosphates and are in general more efficient and less costly to make and use.
    Type: Application
    Filed: March 26, 2003
    Publication date: January 8, 2004
    Inventors: Nancy J. Schoenbrunner, Thomas W. Myers, David H. Gelfand
  • Patent number: 6514736
    Abstract: The present invention is directed to a process for amplifying any target nucleic acid sequence contained in a nucleic acid or mixture thereof using a thermostable enzyme. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers with a thermostable enzyme to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction can be repeated as often as desired and involve temperature cycling to effect hybridization, promotion of activity of the enzyme, and denaturation of the hybrids formed.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: February 4, 2003
    Assignee: Roche Molecular Systems, Inc
    Inventors: Henry A. Erlich, Glenn Horn, Randall K. Saiki, Kary B. Mullis, David H. Gelfand
  • Patent number: 6214979
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides uses the 5′ to 3′ nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and release labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification assay.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: April 10, 2001
    Assignee: Roche Molecular Systems
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Patent number: 6197563
    Abstract: The present invention is directed to a process for amplifying any target nucleic acid sequence contained in a nucleic acid or mixture thereof using a thermostable enzyme. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers with a thermostable enzyme to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction can be repeated as often as desired and involve temperature cycling to effect hybridization, promotion of activity of the enzyme, and denaturation of the hybrids formed.
    Type: Grant
    Filed: November 18, 1994
    Date of Patent: March 6, 2001
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Henry A. Erlich, Glenn Horn, Randall K. Saiki, Kary B. Mullis, David H. Gelfand
  • Patent number: 6127155
    Abstract: A purified thermostable nucleic acid polymerase is obtained that has unique characteristics. Preferably the nucleic acid polymerase is DNA polymerase isolated from a Thermus aquaticus species and has a molecular weight of about 86,000-95,000 daltons. The thermostable nucleic acid polymerase may be native or recombinant and may be used in a temperature-cycling chain reaction wherein at least one nucleic acid sequence is amplified in quantity from an existing sequence with the aid of selected primers and nucleotide triphosphates. The nucleic acid polymerase is preferably stored in a buffer containing non-ionic detergents that lends stability to the nucleic acid polymerase. A preferred buffer contains glycerol, polyoxyethylated sorbitan monolaurate, ethoxylated nonyl phenol and gelatin.
    Type: Grant
    Filed: April 24, 1992
    Date of Patent: October 3, 2000
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Susanne Stoffel, Randall K. Saiki
  • Patent number: 6040166
    Abstract: The present invention is directed to a process for amplifying any target nucleic acid sequence contained in a nucleic acid or mixture thereof using a thermostable enzyme. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers with a thermostable enzyme to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction can be repeated as often as desired and involve temperature cycling to effect hybridization, promotion of activity of the enzyme, and denaturation of the hybrids formed.
    Type: Grant
    Filed: September 27, 1994
    Date of Patent: March 21, 2000
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Henry A. Erlich, Glenn Horn, Randall K. Saiki, Kary B. Mullis, David H. Gelfand